Influence of melatonin pretreatment and preconditioning by hypobaric hypoxia on the development of cortical photothrombotic ischemic lesion

Physiological Research

Volumn 57, Issue 2, 2008, Pages 283-288

  Matejovska I ^a   Bernaskova K ^a   Krysl D ^a,b   Mares J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Animal; Free radicals; Hypoxia; Ischemia; Melatonin; Models

Indexed keywords

ANTIOXIDANT; FREE RADICAL; MELATONIN; NEUROPROTECTIVE AGENT; ROSE BENGAL;

ANIMAL; ANOXIA; ARTICLE; ATMOSPHERIC PRESSURE; BRAIN CORTEX; BRAIN ISCHEMIA; COMPARATIVE STUDY; ENDOTHELIUM CELL; HOSPITALIZATION; ISCHEMIC PRECONDITIONING; LIGHT; MALE; METABOLISM; METHODOLOGY; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOLOGY; RADIATION EXPOSURE; RAT; WISTAR RAT;

ANIMALS; ANOXIA; ANTIOXIDANTS; ATMOSPHERIC PRESSURE; BRAIN ISCHEMIA; CEREBRAL CORTEX; ENDOTHELIAL CELLS; FREE RADICALS; INTRACRANIAL THROMBOSIS; ISCHEMIC PRECONDITIONING; LIGHT; MALE; MELATONIN; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; ROSE BENGAL; SEVERITY OF ILLNESS INDEX;

EID: 45849117664     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ANDREADOU I, ILIODROMITIS EK, MIKROS E, BOFILIS E, ZOGA A, CONSTANTINOU M, TSANTILIKAKOULIDOU A, KREMASTINOS DT: Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med 37: 500-510, 2004.
2. BRUNE B: The intimate relation between nitric oxide and superoxide in apoptosis and cell survival. Antioxid Redox Signal 7: 497-507, 2005.
3. CUZZOCREA S, COSTANTINO G, GITTO E, MAZZON E, FULIA F, SERRAINO I, CORDARO S, BARBERI I, DE SARRO A, CAPUTI A P: Protective effects of melatonin in ischemic brain injury. J Pineal Res 29: 217-227, 2000.
4. DIETRICH W, WATSON B, BUSTO R, GINSBERG M, BETHEA J: Photochemically induced cerebral infarction. I. Early microvascular alterations. Acta Neuropathol (Berl) 72: 315-325, 1987.
5. GUERRERO JM, REITER RJ, ORTIZ GG, PABLOS MI, SEWERYNEK E, CHUANG JI: Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus). J Pineal Res 23: 24-31, 1997.
6. ISHIKAWA M, SEKIZUKA E, OSHIO C, SATO S, YAMAGUCHI N, TERAO S, TSUKADA K, MINAMITANI H, KAWASE T: Platelet adhesion and arteriolar dilation in the photothrombosis: observation with the rat closed cranial and spinal windows. J Neurol Sci 194: 59-69, 2002.
7. JOHNSTON KC, WAGNER DP, WANG XQ, NEWMAN GC, THIJS V, SEN S, WARACH S: Validation of an acute ischemic stroke model: does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke 38: 1820-1825, 2007.
8. KAMSLER A, SEGAL M: Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity. Mol Neurobiol 29: 167-178, 2004.
9. KHAN SH, BAZIANY A, BANIGESH A, HEMMINGS SJ, SHUAIB A: Evaluation of an optimal temperature for brain storage in delayed 2, 3,5-triphenyltetrazolium chloride staining. J Neurosci Methods 98: 43-47, 2000.
10. KILIC U, KILIC E, REITER RJ, BASSETTI CL, HERMANN DM: Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res 38: 67-71, 2005.
11. LIU J, NARASIMHAN P, YU F, CHAN PH: Neuroprotection by hypoxic preconditioning involves oxidative stressmediated expression of hypoxia-inducible factor and erythropoietin. Stroke 36: 1264-1269, 2005.
12. MAREŠ J, POMETLOVÁ M, KRÝSL D, ROKYTA R: Influence of scavengers of reactive oxygen species on learning impairment elicited by flurothyl epileptic seizure. Physiol Res 55: 31P, 2006.
13. PEI Z, PANG SF, CHEUNG RT: Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 32: 168-172, 2002.
14. PEVSNER PH, EICHENBAUM JW, MILLER DC, PIVAWER G, EICHENBAUM KD, STERN A, ZAKIAN KL, KOUTCHER JA: A photothrombotic model of small early ischemic infarcts in the rat brain with histologic and MRI correlation. J Pharmacol Toxicol Methods 45: 227-233, 2001.
15. PUISIEUX F, DEPLANQUE D, BULCKAEN H, MABOUDOU P, GELE P, LHERMITTE M, LEBUFFE G, BORDET R: Brain ischemic preconditioning is abolished by antioxidant drugs but does not up-regulate superoxide dismutase and glutathione peroxidase. Brain Res 1027: 30-37, 2004.
16. REITER RJ, TAN DX, MANCHESTER LC, LOPEZ-BURILLO S, SAINZ RM, MAYO JC: Melatonin: detoxification of oxygen and nitrogen-based toxic reactants. Adv Exp Med Biol 527: 539-548, 2003.
17. RODRIGUEZ C, MAYO J C, SAINZ RM, ANTOLIN I, HERRERA F, MARTIN V, REITER RJ: Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36: 1-9, 2004.
18. SHARP F R, RAN R, LU A, TANG Y, STRAUSS K I, GLASS T, ARDIZZONE T, BERNAUDIN M: Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 1: 26-35, 2004.
19. SUGIMORI H, YAO H, OOBOSHI H, IBAYASHI S, IIDA M: Krypton laser-induced photothrombotic distal middle cerebral artery occlusion without craniectomy in mice. Brain Res Brain Res Protoc 13: 189-196, 2004.
20. TAN DX, REITER R J, MANCHESTER LC, YAN MT, EL-SAWI M, SAINZ RM, MAYO JC, KOHEN R, ALLEGRA M, HARDELAND R: Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2: 181-197, 2002.
21. TEJKALOVÁ H, KAISER M, KLASCHKA J, ŠŤASTNÝ F: Does neonatal brain ischemia induce schizophrenia-like behavior in young adult rats? Physiol Res 56: 815-823, 2007.
22. TUTUNCULER F, ESKIOCAK S, BASARAN U N, EKUKLU G, AYVAZ S, VATANSEVER U: The protective role of melatonin in experimental hypoxic brain damage. Pediatr Int 47: 434-439, 2005.
23. WAKATSUKI A, OKATANI Y, IZUMIYA C, IKENOUE N: Melatonin protects against ischemia and reperfusioninduced oxidative lipid and DNA damage in fetal rat brain. J Pineal Res 26: 147-152, 1999.
24. WATSON B, DIETRICH W, BUSTO R, WACHTEL M, GINSBERG M: Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 17: 497-504, 1985.
25. WATSON B, DIETRICH W, PRADO R, GINSBERG M: Argon laser-induced arterial photothrombosis. Characterization and possible application to therapy of arteriovenous malformations. J Neurosurg 66: 748-754, 1987.
26. XI GM, WANG HQ, HE GH, HUANG CF, WEI GY: Evaluation of murine models of permanent focal cerebral ischemia. Chin Med J (Engl) 117: 389-394, 2004.
27. YAO H, SUGIMORI H, FUKUDA K, TAKADA J, OOBOSHI H, KITAZONO T, IBAYASHI S, IIDA M: Photothrombotic middle cerebral artery occlusion and reperfusion laser system in spontaneously hypertensive rats. Stroke 34: 2716-2721, 2003.
28. YELESWARAM K, MCLAUGHLIN LG, KNIPE J O, SCHABDACH D: Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J Pineal Res 22: 45-51, 1997.
29. ZOU LY, CHEUNG RT, LIU S, LI G, HUANG L: Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice. J Pineal Res 41: 150-156, 2006.